Search results
Does NovoCure (NVCR) Have the Potential to Rally 63.51% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 3 months agoThe mean of analysts' price targets for NovoCure (NVCR) points to a 63.5% upside in the stock. While...
Is NovoCure Limited (NASDAQ:NVCR) Worth US$16.0 Based On Its Intrinsic Value?
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights NovoCure's estimated fair value is US$12.01 based on 2 Stage Free Cash Flow to Equity...
Should You Hold NovoCure Limited (NVCR)?
Insider Monkey via Yahoo Finance· 9 months agoClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” second quarter 2023 investor letter. A copy of...
Should You Investigate NovoCure Limited (NASDAQ:NVCR) At US$87.50?
Simply Wall St. via Yahoo Finance· 1 year agoWhile NovoCure Limited (NASDAQ:NVCR) might not be the most widely known stock at the moment, it...
NovoCure Limited (NASDAQ:NVCR) institutional owners may be pleased with recent gains after 85% loss...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Given the large stake in the stock by institutions, NovoCure's stock price might be...
NovoCure (NVCR) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNovoCure (NVCR) delivered earnings and revenue surprises of 16.67% and 2.85%, respectively, for the...
After losing 33% in the past year, NovoCure Limited (NASDAQ:NVCR) institutional owners must be...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls NovoCure Limited (NASDAQ:NVCR), then you'll have to look at...
Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes
Investor's Business Daily· 1 year agoNovocure announced a series of C-suite changes on Thursday as investor debate continues to haunt its...
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoNovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats...
Novocure Skyrockets 69% After Pulling Off A Once-In-Six-Years Feat
Investor's Business Daily· 1 year agoAdding Novocure's medical device to standard drugs improved survival for late-stage lung cancer...